This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Parkinson's disease and anxiety

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

A third of Parkinson's disease (PD) patients suffer from an anxiety disorder at any time point (1)

  • can precede or follow PD motor symptoms
  • anxiety is associated with demographic, disease-related motor and non-motor features

Retrospective study (UK data) found risk of developing Parkinson’s disease (PD) was at least doubled in people with anxiety vs those without (2):

  • in those with anxiety, the presence of depression, hypotension, tremor, rigidity, balance impairment, constipation, sleep disturbance, fatigue, and cognitive impairment were associated with an increased risk of developing PD
    • clinical features of those who developed PD can help identify patients presenting with anxiety who are in the prodromal phase of PD
    • study confirmed that depression, sleep disturbance, fatigue, cognitive impairment, hypotension, tremor, rigidity, balance impairment, and constipation are risk factors for developing PD

Reference:

  • Abou Kassm S, Naja W, Haddad R, Pelissolo A. The Relationship Between Anxiety Disorders and Parkinson's Disease: Clinical and Therapeutic Issues. Curr Psychiatry Rep. 2021 Mar 3;23(4):20. Baz0-Alvarez JC et al.
  • Risk of Parkinson’s disease in people with New Onset Anxiety over 50 years - Incidence and Associated Features. BJGP 21 March 2024 DOI: 10.3399/BJGP.2023.0423

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.